14 results on '"Bunse, Theresa"'
Search Results
2. T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticles
3. AMPLIFY-NEOVAC: a randomized, 3-arm multicenter phase I trial to assess safety, tolerability and immunogenicity of IDH1-vac combined with an immune checkpoint inhibitor targeting programmed death-ligand 1 in isocitrate dehydrogenase 1 mutant gliomas
4. A vaccine targeting mutant IDH1 in newly diagnosed glioma
5. Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate
6. A Cellular Ground Truth to Develop MRI Signatures in Glioma Models by Correlative Light Sheet Microscopy and Atlas-Based Coregistration.
7. In vivo nanoparticle-based T cell imaging can predict therapy response towards adoptive T cell therapy in experimental glioma.
8. Dysfunctional dendritic cells limit antigen-specific T cell response in glioma.
9. Clinical and Translational Advances in Glioma Immunotherapy.
10. Concepts in glioma immunotherapy.
11. Genetically Modified Cellular Therapies for Malignant Gliomas.
12. ATIM-33. NOA-16: A FIRST-IN-MAN MULTICENTER PHASE I CLINICAL TRIAL OF THE GERMAN NEUROONCOLOGY WORKING GROUP EVALUATING A MUTATION-SPECIFIC PEPTIDE VACCINE TARGETING IDH1R132H IN PATIENTS WITH NEWLY DIAGNOSED MALIGNANT ASTROCYTOMAS.
13. IMMU-54. THE ONCOMETABOLITE R-2-HYDROXYGLUTARATE SUPPRESSES THE INNATE IMMUNE MICROENVIRONMENT OF IDH1-MUTATED GLIOMAS VIA ARYL HYDROCARBON RECEPTOR SIGNALING.
14. K27M-mutant histone-3 as a novel target for glioma immunotherapy.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.